Home » Nanogen

Nanogen

Apr 18, 2003
Premium

Nanogen last week rolled out kits for the detection of Alzheimer’s disease, Canavan disease, and beta thalassemia. The Alzheimer’s and Canavan products are analyte-specific reagents for creating tests for mutations. All three products are used on NanoChip microarrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Blame the Follicles

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Missed a Few

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

This Week in Cell

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Yep, Couple of Concerns There

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

What's Popular?

In Microarrays & Multiplexing

  1. Epilepsy GWAS Leads to New Loci, Potential Drug Targets

  2. Amended Lawsuit Against Illumina, Thermo Fisher, Others Names Additional Defendants

  3. Genome-Wide Study Uncovers Variants Explaining Majority of SNP Heritability of Red Hair

  4. Illumina Donates Genotyping Arrays to All of Us Research Program

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.